Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $605.78 million. The enterprise value is $982.66 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 164.61 million shares outstanding. The number of shares has increased by 2.82% in one year.
| Current Share Class | 164.61M |
| Shares Outstanding | 164.61M |
| Shares Change (YoY) | +2.82% |
| Shares Change (QoQ) | +2.62% |
| Owned by Insiders (%) | 2.47% |
| Owned by Institutions (%) | 76.31% |
| Float | 135.34M |
Valuation Ratios
The trailing PE ratio is 5.96 and the forward PE ratio is 3.26.
| PE Ratio | 5.96 |
| Forward PE | 3.26 |
| PS Ratio | 1.68 |
| Forward PS | 1.28 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.40 |
| P/OCF Ratio | 5.40 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 4.82, with an EV/FCF ratio of 8.76.
| EV / Earnings | 9.62 |
| EV / Sales | 2.72 |
| EV / EBITDA | 4.82 |
| EV / EBIT | 4.86 |
| EV / FCF | 8.76 |
Financial Position
The company has a current ratio of 1.41
| Current Ratio | 1.41 |
| Quick Ratio | 1.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.89 |
| Debt / FCF | 5.32 |
| Interest Coverage | 5.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 33.15% |
| Return on Invested Capital (ROIC) | 85.92% |
| Return on Capital Employed (ROCE) | 101.90% |
| Weighted Average Cost of Capital (WACC) | 4.64% |
| Revenue Per Employee | $3.62M |
| Profits Per Employee | $1.02M |
| Employee Count | 100 |
| Asset Turnover | 0.95 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $69.29 million in taxes.
| Income Tax | 69.29M |
| Effective Tax Rate | 40.41% |
Stock Price Statistics
The stock price has increased by +401.50% in the last 52 weeks. The beta is 0.30, so IRWD's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +401.50% |
| 50-Day Moving Average | 3.78 |
| 200-Day Moving Average | 2.95 |
| Relative Strength Index (RSI) | 41.42 |
| Average Volume (20 Days) | 2,345,121 |
Short Selling Information
The latest short interest is 18.19 million, so 11.05% of the outstanding shares have been sold short.
| Short Interest | 18.19M |
| Short Previous Month | 17.90M |
| Short % of Shares Out | 11.05% |
| Short % of Float | 13.44% |
| Short Ratio (days to cover) | 6.23 |
Income Statement
In the last 12 months, IRWD had revenue of $361.51 million and earned $102.18 million in profits. Earnings per share was $0.62.
| Revenue | 361.51M |
| Gross Profit | 271.87M |
| Operating Income | 202.03M |
| Pretax Income | 171.47M |
| Net Income | 102.18M |
| EBITDA | 203.88M |
| EBIT | 202.03M |
| Earnings Per Share (EPS) | $0.62 |
Full Income StatementBalance Sheet
The company has $220.47 million in cash and $597.36 million in debt, with a net cash position of -$376.89 million or -$2.29 per share.
| Cash & Cash Equivalents | 220.47M |
| Total Debt | 597.36M |
| Net Cash | -376.89M |
| Net Cash Per Share | -$2.29 |
| Equity (Book Value) | -217.14M |
| Book Value Per Share | -1.32 |
| Working Capital | 95.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $112.21 million and capital expenditures -$3,000, giving a free cash flow of $112.21 million.
| Operating Cash Flow | 112.21M |
| Capital Expenditures | -3,000 |
| Depreciation & Amortization | 1.85M |
| Net Borrowing | n/a |
| Free Cash Flow | 112.21M |
| FCF Per Share | $0.68 |
Full Cash Flow StatementMargins
Gross margin is 75.20%, with operating and profit margins of 55.89% and 28.26%.
| Gross Margin | 75.20% |
| Operating Margin | 55.89% |
| Pretax Margin | 47.43% |
| Profit Margin | 28.26% |
| EBITDA Margin | 56.40% |
| EBIT Margin | 55.89% |
| FCF Margin | 31.04% |
Dividends & Yields
IRWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.82% |
| Shareholder Yield | -2.82% |
| Earnings Yield | 16.87% |
| FCF Yield | 18.52% |
Analyst Forecast
The average price target for IRWD is $7.67, which is 108.42% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.67 |
| Price Target Difference | 108.42% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | -3.35% |
| EPS Growth Forecast (5Y) | 10.57% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRWD has an Altman Z-Score of -2.31 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.31 |
| Piotroski F-Score | 7 |
